Scarica l'app Stockscreener
8.20
1.11%
0.09
Panoramica
Notizia
Cronologia dei prezzi
Catena di opzioni
Financials
Perché AURA Giù?
Forum
Previsione
Precedente Chiudi:
$8.11
Aprire:
$8.03
Volume 24 ore:
582.44K
Relative Volume:
2.87
Capitalizzazione di mercato:
$409.60M
Reddito:
-
Utile/perdita netta:
$-76.41M
Rapporto P/E:
-4.10
EPS:
-2
Flusso di cassa netto:
$-64.56M
1 W Prestazione:
-2.50%
1M Prestazione:
-6.29%
6M Prestazione:
+18.33%
1 anno Prestazione:
-3.07%
Intervallo 1D:
$8.01
$8.43
Intervallo di 1 settimana:
$8.01
$9.04
Portata 52W:
$6.63
$12.38
Aura Biosciences Inc Stock (AURA) Company Profile
Nome
Aura Biosciences Inc
Settore
Industria
Telefono
(617)500-8864
Indirizzo
80 GUEST STREET, BOSTON
Confronta AURA con altri titoli
| Azioni | Prezzo | Cap. di mercato | Reddito | Reddito netto | Flusso di cassa | EPS |
|---|---|---|---|---|---|---|
AURA
Aura Biosciences Inc
|
8.20 | 409.60M | 0 | -76.41M | -64.56M | -1.92 |
|
VRTX
Vertex Pharmaceuticals Inc
|
397.27 | 102.31B | 10.63B | -479.80M | -1.35B | -1.99 |
|
REGN
Regeneron Pharmaceuticals Inc
|
701.85 | 77.13B | 13.85B | 4.65B | 3.32B | 40.41 |
|
ARGX
Argen X Se Adr
|
623.82 | 37.30B | 1.86B | -40.29M | -1.28B | -0.85 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
245.44 | 31.66B | 2.09B | -332.26M | 16.06M | -2.62 |
|
BNTX
Biontech Se Adr
|
113.08 | 27.11B | 3.30B | -501.07M | 1.03B | -2.1146 |
Aura Biosciences Inc Stock (AURA) Upgrades & Downgrades
| Data | Azione | Analista | Modifica della valutazione |
|---|---|---|---|
| 2024-07-25 | Iniziato | H.C. Wainwright | Buy |
| 2023-07-27 | Iniziato | Scotiabank | Sector Outperform |
| 2023-04-17 | Ripresa | BTIG Research | Buy |
| 2022-07-19 | Iniziato | JMP Securities | Mkt Outperform |
Aura Biosciences Inc Borsa (AURA) Ultime notizie
Aura Biosciences, Inc. (NASDAQ:AURA) Shares Purchased by Franklin Resources Inc. - MarketBeat
Wellington Management Group LLP Takes $1.04 Million Position in Aura Biosciences, Inc. (NASDAQ:AURA) - MarketBeat
Aura Biosciences, Inc. (NASDAQ:AURA) Shares Sold by Fmr LLC - MarketBeat
Aura Biosciences, Inc. (NASDAQ:AURA) Sees Significant Growth in Short Interest - MarketBeat
How the (AURA) price action is used to our Advantage - Stock Traders Daily
Learn to Evaluate (AURA) using the Charts - Stock Traders Daily
Aura Biosciences to Participate in the 7th Annual Evercore ISI HealthCONx Conference - GlobeNewswire
Cabaletta Bio to Participate in Upcoming Investor Conferences in December - The Manila Times
Aura Biosciences CEO to Present at Evercore ISI HealthCONx Conference | AURA Stock News - StockTitan
Teladoc (TDOC) Harnesses AI for Diabetes Care, Stock Rises 6.7% - MSN
When (AURA) Moves Investors should Listen - Stock Traders Daily
Aura Biosciences' chief medical officer sells $110,663 in stock By Investing.com - Investing.com Nigeria
Aura Biosciences' chief medical officer sells $110,663 in stock - Investing.com
HC Wainwright Forecasts Higher Earnings for Aura Biosciences - Defense World
HC Wainwright Has Bullish Forecast for AURA FY2024 Earnings - MarketBeat
Aura Biosciences, Inc. (NASDAQ:AURA) Short Interest Update - MarketBeat
Aura Biosciences’ (AURA) Buy Rating Reiterated at HC Wainwright - Defense World
What is Leerink Partnrs’ Estimate for AURA FY2024 Earnings? - Defense World
Leerink Partnrs Has Strong Forecast for AURA FY2024 Earnings - MarketBeat
Citadel Advisors LLC Reduces Stake in Aura Biosciences Inc - GuruFocus.com
Brokerages Set Aura Biosciences, Inc. (NASDAQ:AURA) Target Price at $23.00 - Defense World
HC Wainwright Reaffirms Buy Rating for Aura Biosciences (NASDAQ:AURA) - MarketBeat
Aura Biosciences Reports Q3 Financial Results - TipRanks
Aura Stock Up as Lead Drug Shows Superior Efficacy in Eye Cancer Study - MSN
Aura Biosciences : Reports Third Quarter 2024 Financial Results and Business Highlights Form 8 K - Marketscreener.com
Aura Biosciences Reports Third Quarter 2024 Financial Results and Business Highlights - GlobeNewswire
Aura Biosciences, Inc. Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2024 - Marketscreener.com
Aura Biosciences, Inc. (NASDAQ:AURA) Receives Average Rating of "Buy" from Analysts - MarketBeat
(AURA) Investment Analysis - Stock Traders Daily
Clearside's Eye Treatment Platform Gains Momentum with Major Santen Partnership in China - StockTitan
One Aura Biosciences Insider Raised Stake By 232% In Previous Year - Yahoo Finance
Short Interest in Aura Biosciences, Inc. (NASDAQ:AURA) Decreases By 8.7% - MarketBeat
Aura Biosciences, Inc. (NASDAQ:AURA) Insider Sells $98,808.00 in Stock - MarketBeat
Aura Biosciences VP sells shares worth $5,938 By Investing.com - Investing.com Australia
Aura Biosciences CEO Elisabet de los Pinos sells $98,787 in stock By Investing.com - Investing.com South Africa
Aura Biosciences CEO Elisabet de los Pinos sells $98,787 in stock - Investing.com
Aura Biosciences VP sells shares worth $5,938 - Investing.com
Don't Ignore The Insider Selling In Aura Biosciences - Simply Wall St
Aura Biosciences (NASDAQ:AURA) Stock Price Down 4.9% After Insider Selling - Defense World
Aura Biosciences CFO Julie Feder sells shares worth $302,361 - Investing.com India
Aura Biosciences (NASDAQ:AURA) Trading Down 4.9% on Insider Selling - MarketBeat
Aura Biosciences, Inc. (NASDAQ:AURA) CFO Sells $302,325.93 in Stock - MarketBeat
Aura Biosciences: 2 Positive Bel-Sar Data Releases Brings Shareholder Value - Seeking Alpha
Aura Biosciences, Inc. (NASDAQ:AURA) Receives $23.00 Average Price Target from Analysts - Defense World
Long Term Trading Analysis for (AURA) - Stock Traders Daily
Aura Biosciences (NASDAQ:AURA) PT Raised to $22.00 at HC Wainwright - Defense World
Aura Biosciences stock hits 52-week high at $12.38 By Investing.com - Investing.com Australia
Aura Biosciences CEO sells $300,838 in stock By Investing.com - Investing.com Australia
Aura Biosciences reports promising early trial results - Investing.com India
Insider Selling: Aura Biosciences, Inc. (NASDAQ:AURA) Insider Sells 24,992 Shares of Stock - MarketBeat
Aura Biosciences Inc Azioni (AURA) Dati Finanziari
Reddito
Reddito netto
Flusso di cassa
EPS
2.88%
2.65%
Apri su Yahoo
|
Apri su Google
|
Aperto in Finviz
|
Apri in MarketWatch
|
Aperto a EDGAR
|
Aperto su Reuters
Capitalizzazione:
|
Volume (24 ore):